Fig. 4.
![Fig. 4. Dose-dependent effects of indinavir or saquinavir on T-cell proliferation and apoptosis. / Results represent the mean ± SD of [3H]-thymidine uptake (A and B) and percentage apoptotic cells upon TCR/CD3 ligation with anti-CD3 antibodies (C and D) or upon Fas ligation with anti-Fas antibodies (E and F) in 10 healthy donor PBMCs (□) and 10 untreated HIV-1 patient PBMCs (▪).](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/96/1/10.1182_blood.v96.1.250/4/bloo01328004x.jpeg?Expires=1724235513&Signature=gqC889Rcckd-h13~eEaqmneW2xny8s6daX73c4t4xygOaO4G3XPAqiBm~lLtRBeChxFzhrvRi6zBmqewwnre77kxRcxPF-r6wXo6BmAxJdsX-yVDzA-K1yBLWFHo0ImNrSbgIUK2Ib7FmFUTZd-iBffU0Ftt1VrjnKb~PtUmRsAJCJnQt0IqZHfMgtiAK6l4KXTAFXeuIAyiYwBBM1YpYbdyyP-9eHhJEv2Ztg3JlJB-1OoCQt4rMPN4~vc3otzcKK2abU~v-jJCdQrpyaiDUwKEN2KHCMjV8r4QYAJrhR-VAAZOV2ANlECWSqr8hJ~ajaiirzNU-TwTSjapmy1B6A__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Dose-dependent effects of indinavir or saquinavir on T-cell proliferation and apoptosis.
Results represent the mean ± SD of [3H]-thymidine uptake (A and B) and percentage apoptotic cells upon TCR/CD3 ligation with anti-CD3 antibodies (C and D) or upon Fas ligation with anti-Fas antibodies (E and F) in 10 healthy donor PBMCs (□) and 10 untreated HIV-1 patient PBMCs (▪).
